SpaceX shares closed below their $135 IPO price for the first time on Wednesday, marking a 42% decline from the post-listing peak reached within days of the stock beginning to trade. The orbital-services and launch provider set its offering price publicly before the deal priced, abandoning the traditional Wall Street book-building process, and has now given back the entire initial pop that briefly valued the company at levels exceeding $300 billion.
The stock peaked at approximately $233 per share in the days following its market debut, then began a continuous decline that accelerated through the second week of trading. By Wednesday's close, shares had breached the $135 level Elon Musk and his advisors locked in before the offering. Volume remained elevated throughout the slide, suggesting institutional repositioning rather than technical washing. The company raised roughly $6.7 billion in the IPO, pricing 50 million shares at the predetermined level, with no underwriter discount and no traditional syndicate stabilization mechanism.
This matters because SpaceX represented the first PLATINUM-tier name to reject the conventional IPO apparatus entirely. Musk eliminated the underwriter's price-discovery role, the roadshow feedback loop, and the green-shoe over-allotment structure that typically supports new issues in their first 30 days. The result is a live experiment in what happens when a founder with sufficient brand leverage bypasses the stabilization mechanisms Wall Street developed over decades. The 42% drawdown in under a month is now the reference case for every other founder considering a similar path. Allocators who took size in the deal are sitting on mark-to-market losses that would have triggered claw-back conversations in a traditional structure.
The secondary effect is structural. Family offices and crossover funds that received direct allocations—bypassing mutual funds and pension managers who typically anchor IPO books—are now facing redemption pressure or internal questions about the decision framework that led them into the name at $135. Several large single-family offices are known to have taken nine-figure positions in the offering, expecting the Musk premium to persist through at least the first earnings cycle. That thesis has now been tested and found insufficient. The absence of a stabilization bid means there is no technical floor beneath the stock until it finds natural buying interest, and that level appears to be materially below the IPO price.
Operators and allocators should watch three specific events over the next 60 days. First, SpaceX's first quarterly earnings release as a public company, expected in mid-May, will clarify whether the Starlink subscriber trajectory and Starship development costs justify the original $135 price or suggest further downside. Second, any indication that Musk is considering a secondary offering or insider sale will signal whether he views current levels as oversold or structurally appropriate. Third, the behavior of the family offices and direct allocators who took size in the deal—whether they add to positions below $135 or remain passive—will determine whether this becomes a case study in founder hubris or a temporary mispricing that sophisticated capital exploited.
The $135 level is now a psychological marker in the same way that $420 became one for Tesla in 2018. SpaceX closed Wednesday at $132, and the next support level appears to be the $110-$115 range where several large crossover funds were rumored to have been buyers in the final private round before the IPO. If that level fails, the company will have erased not only its public-market premium but also the valuation gains from its last twelve months as a private entity.